2007
DOI: 10.1001/jama.298.22.2644
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

26
919
4
42

Year Published

2009
2009
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 1,272 publications
(1,021 citation statements)
references
References 41 publications
26
919
4
42
Order By: Relevance
“…The current PRE-DELIRIC model may require on-going validation as new therapies and interventions emerge. For example, the use of new sedatives or analgesics may affect the development of delirium [33][34][35] and consequently could affect the performance of the model. Different risk factors may emerge in the future that may need to be investigated and included in the current PRE-DELIRIC model.…”
Section: Discussionmentioning
confidence: 99%
“…The current PRE-DELIRIC model may require on-going validation as new therapies and interventions emerge. For example, the use of new sedatives or analgesics may affect the development of delirium [33][34][35] and consequently could affect the performance of the model. Different risk factors may emerge in the future that may need to be investigated and included in the current PRE-DELIRIC model.…”
Section: Discussionmentioning
confidence: 99%
“…The benefit attributed to remifentanil in some of the above studies could have been either a surrogate of the harmful effect of midazolam or dependent upon an interaction between the choice of opioid and midazolam. A recent study reported the harmful effects of lorazepam when compared with dexmedetomidine in a mixed surgical and medical ICU population [23].…”
Section: Discussionmentioning
confidence: 99%
“…One major limitation of the trial was the depth of sedation, which was chosen by the primary team. Baseline RASS scores for the dexmedetomidine and lorazepam groups were -3 and -4 respectively [35]. Had lighter or 'cooperative' sedation goals been achieved (closer to 0 to -1), the incidence of drug-induced coma would likely have been less (particularly with lorazepam), and results may have diff ered.…”
Section: Comparative Trialsmentioning
confidence: 98%
“…Th ere are, however, several important trials comparing agents. Th e Maximizing Effi cacy of Targeted Sedation and Reducing Neurological Dysfunction (MENDS) trial was the fi rst randomized, double-blind trial evaluating the eff ect of sedative agents on delirium-free and coma-free days [35]. Th e two agents compared in this trail were lorazepam and dexmedetomidine.…”
Section: Comparative Trialsmentioning
confidence: 99%